Sharps Technology and GE HealthCare Technologies Compared

A critical review of the two medical companies and which is the better investment

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Sharps Technology (NASDAQ:STSS) and GE HealthCare Technologies (NASDAQ:GEHC) are both medical companies, but a comparison of the two reveals GE HealthCare Technologies as the stronger investment option based on factors like revenue, earnings, valuation, and analyst recommendations.

Why it matters

This analysis provides investors with a detailed comparison of two prominent medical technology companies, helping them make a more informed decision on where to allocate their capital.

The details

The analysis looks at key metrics like net margins, return on equity, return on assets, revenue, earnings per share, and valuation. It also examines the companies' stock volatility, analyst recommendations, and consensus price targets. Overall, the data shows GE HealthCare Technologies outperforming Sharps Technology on most measures.

  • The analysis was published on March 10, 2026.

The players

Sharps Technology

A medical device company that researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States.

GE HealthCare Technologies

A company that engages in the development, manufacture, and marketing of medical products, services, and digital solutions used in diagnosis, treatment, and patient monitoring, with operations in the United States, Canada, and internationally.

Got photos? Submit your photos here. ›

The takeaway

This analysis highlights GE HealthCare Technologies as the more attractive investment option compared to Sharps Technology based on its stronger financial performance, lower volatility, and more favorable analyst consensus. Investors looking to gain exposure to the medical technology sector may want to consider GE HealthCare Technologies as a potential investment.